White Papers

Download this application note from PHC Corporation of North America to learn how 3D cell culture more closely models in vivo conditions and captures clinically relevant results. 

Quantitative reverse transcription PCR (RT-qCR) involves the detection and quantification of RNA. The process is performed by reverse transcription of the enzyme reverse transcriptase, followed by amplification and detection of the specific targets of this DNA using a technique called quantitative PCR (qPCR) or real-time PCR.  

Determining Nanoparticle Vaccine Construct Design Stability and Antigenic Efficiency by Improving Nanoparticle Vaccine Design with BLI.

Eppendorf performed fed-batch cultures using BioBLU® 1c and 3c Single-Use Vessels controlled in parallel by the new SciVario® twin bioreactor control system.

Download this whitepaper to discover practical applications of data integrity and audit trail review

Business Process Management (BPM) has emerged as a proven technology that helps companies meet objectives and gain competitive advantage.

The Accuri® C6 Flow Cytometer® represents a dramatic step forward in flow cytometry and cell analysis. Now researchers have access to a high-capability analytical cytometer at an affordable price. The benchtop-sized C6 makes a powerful research tool available to a much wider range of life scientists. This article examines a variety of biological applications that take advantage of the C6’s cellular analysis capabilities.

Presented here is a new method for in situ RNA detection, the Stellaris™ FISH technology, which enables simultaneous detection, localization, and quantification of individual RNA molecules at the cellular level. This technique provides a high degree of specificity and sensitivity, is ideal for applications that analyze transcription site activity, protein- RNA interactions and mRNA translocation events, and holds promise for future diagnostic applications.

SDIX® has developed an antibody engine (mAb discovery engine) for discovery of antibodies to transmembrane proteins like G-protein coupled receptors (GPCRs). The mAb discovery engine generates panels of diverse antibodies in terms of sequence, somatic hypermutation, epitopes, and performance. The mAb discovery engine is a platform that is capable of routinely generating antibody candidates that are diverse, functional and novel.